Membrane Potential Mapping with18F-TPP

StatusRecruiting
PhasePhase 1
Started

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Track this trial
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date pushed from Aug 2026 to Oct 2026
    • Eligibility criteria expanded, about 16 words
    • Study description expanded, about 3 words
  2. Recruitment opened
    • Start date: Jun 2026 to Aug 2026
    • Site details revised
    v3
  3. Start date: Apr 16, 2026 to Jun 2026v2
  4. Study First Submitted
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
Yale University
490 trials monitored
See 31 trials at risk
In this study, investigators propose to use PET imaging to study the pharmacokinetics of 18F-TPP and develop methods for imaging membrane potential (ΔΨT) in humans.
Trial Details
NCT Number NCT07506616
Lead Sponsor Yale University
Collaborators: National Institute for Biomedical Imaging and Bioengineering (NIBIB)
Conditions
(from sponsor)		 Membrane Potential Mapping
Enrollment 24 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov